Odyssey Health (ODYY) EBIT Margin (2014 - 2016)

Odyssey Health (ODYY) posted EBIT Margin of 207.5% for Q3 2016, down 1394.46% on a QoQ basis from 13.88% in Q2 2016.

Analysis

Odyssey Health (ODYY) EBIT Margin (2014 - 2016) Analysis & Trends

Odyssey Health has reported EBIT Margin for 3 years, with the latest figure at 207.5% in Q3 2016.

On a quarterly basis, EBIT Margin changed N/A year-over-year to 207.5% in Q3 2016; TTM through Apr 2017 was 972.18%, a 67667.0% decrease from a year earlier, with the FY2016 full-year figure at 196.43%, down 13582.0% from the prior year.
EBIT Margin was 207.5% for Q3 2016 at Odyssey Health, down from 13.88% in the prior quarter.
The five-year high for EBIT Margin was 13.88% in Q2 2016, with the low at 235.48% in Q2 2015.
Average EBIT Margin over 3 years is 106.97%, with a median of 49.03% recorded in 2015.
The largest YoY upside for EBIT Margin was 22159 bps in 2016 against a maximum downside of 22159 bps in 2016.
Over 3 years, EBIT Margin stood at 28.98% in 2014, then tumbled by 712 bps to 235.48% in 2015, then advanced by 12 bps to 207.5% in 2016.
The last three EBIT Margin figures came in at 207.5% (Q3 2016), 13.88% (Q2 2016), and 235.48% (Q2 2015), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	Abbott Laboratories	184.12 Bn	178.52 Bn	7.27 Bn	13.44%
2	Intuitive Surgical	124.45 Bn	119.23 Bn	1.96 Bn	33.60%
3	Medtronic	118.19 Bn	109.37 Bn	6.34 Bn	18.08%
4	Stryker	104.51 Bn	101.03 Bn	4.50 Bn	25.18%
5	Boston Scientific	66.41 Bn	65.87 Bn	3.85 Bn	21.65%
6	Edwards Lifesciences	49.67 Bn	45.42 Bn	1.35 Bn	29.48%
7	Alcon	33.96 Bn	32.51 Bn	1.68 Bn	0.40%
8	Dexcom	32.19 Bn	30.24 Bn	830.00 Mn	24.33%
9	Steris	21.13 Bn	20.65 Bn	684.20 Mn	19.15%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Historic Data

Download Data